We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000725:KRXHyundai Engineering & Construction Co.,Ltd. Analysis

Data as of 2026-07-18 - not real-time

₩47,250.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hyundai Engineering & Construction is trading at KRW 47,250, just above the computed support of KRW 46,800 and well below its 20‑day SMA of KRW 50,585, indicating short‑term pressure. The 14‑day RSI sits at 36.7, hinting at mild oversold conditions, while the MACD histogram turned positive (≈65) and the signal is labeled bullish, though the broader trend remains bearish with decreasing volume. Fundamentally, the company posted a 15.8% revenue decline, narrow gross margin of 6.6%, and negative operating and free cash flow, while carrying a debt‑to‑equity ratio of 38.4, suggesting financial strain.
Despite these challenges, the stock’s price‑to‑sales ratio of 0.18 is low relative to the industry average, and a 1.8% dividend yield with a modest 22% payout offers some income appeal. Volatility is high at 56% over the past 30 days and the max drawdown exceeds 42%, underscoring the risk, yet the beta of 0.89 points to lower market‑wide sensitivity. Overall, the equity appears undervalued on a relative basis but faces considerable near‑term downside risk.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price near 52‑week low and support level
  • Bearish trend with decreasing volume
  • RSI indicating oversold momentum

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Weak earnings and negative cash flow
  • High debt burden limiting flexibility
  • Attractive dividend yield despite sustainability concerns

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Low price‑to‑sales suggesting valuation floor
  • Long‑term infrastructure demand in Asia and Africa
  • Potential upside if cash‑flow and debt profile improve

Key Metrics & Analysis

Financial Health

Revenue Growth-15.80%
Profit Margin1.43%
ROE5.76%
ROA1.19%
Debt/Equity38.36
Op. Cash Flow₩-1138732040192
Free Cash Flow₩-1391086927872
Industry P/E30.8

Technical Analysis

TrendBearish
RSI36.7
Support₩46,800.00
Resistance₩57,200.00
MA 20₩50,585.00
MA 50₩57,038.00
MA 200₩60,857.50
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

GradeUndervalued
TypeValue
Dividend Yield1.80%

Risk Assessment

Beta0.89
Volatility56.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.